Nisarg Maheshkumar Patel

Nisarg Maheshkumar Patel

Active Director Director DIN 07644231
DIN 07644231 First appointment Feb 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 1 historical roles
Total affiliations 7 Since Feb 2017
Shareholding value •••• Premium profile

About Nisarg Maheshkumar Patel

Data last updated:

Nisarg Maheshkumar Patel is a Director at Sini Pharma Private Limited (since 2021), Designated Partner at Sini Healthcare Llp (since 2020) and Director at Serifos Pharma Private Limited (since 2022), and holds 3 more current directorships. The companies operate in Pharma and Real Estate and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹8.89 Cr; the largest is Sini Pharma Private Limited at ₹8.13 Cr (FY 2025). Earlier, Nisarg Maheshkumar Patel was a Director at Sini Brook Biotech Private Limited (from 2022).

DIN 07644231
Primary Designation Director
Industry Pharma
First Appointment 27 Feb 2017
Oldest Company Age 9 yrs
Largest company Sini Pharma Private Limited · ₹8.13 Cr (FY 2025)
Combined revenue ₹8.89 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sini Pharma Private Limited U24299GJ2021PTC125950
Director29 Sep 20212021₹8.13 Cr (FY 2025)Active
Designated Partner02 Sep 20202020₹75.6 Lakh (FY 2024)Active
Serifos Pharma Private Limited U24290GJ2022PTC131025
Director15 Apr 20222022Active
Aetos Pharma Private Limited U24304GJ2021PTC125647
Director16 Sep 20212021Active
Designated Partner23 Aug 20172017Active
Partner27 Feb 20172017Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sini Brook Biotech Private Limited U24200GJ2022PTC129491
Director18 Feb 20222022Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sini Healthcare Llp
Sini Brook Biotech Private Limited
Serifos Pharma Private Limited
Sini Pharma Private Limited
Premium access

Shareholding and investment profile for Nisarg Maheshkumar Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nisarg Maheshkumar Patel

Nisarg Maheshkumar Patel currently holds 6 directorships: Sini Pharma Private Limited (Director, since 29 Sep 2021, revenue ₹8.13 Cr (FY 2025)); Sini Healthcare Llp (Designated Partner, since 02 Sep 2020, revenue ₹75.6 Lakh (FY 2024)); Serifos Pharma Private Limited (Director, since 15 Apr 2022); Aetos Pharma Private Limited (Director, since 16 Sep 2021); Blue Lotus Luxury Homes Llp (Designated Partner, since 23 Aug 2017); and 1 more.

Nisarg Maheshkumar Patel was first appointed on 27 Feb 2017 as Partner at Joyance Realtors Llp. The most recent appointment on record is 15 Apr 2022 at Serifos Pharma Private Limited.

The 2 current companies of Nisarg Maheshkumar Patel that report revenue have a combined latest revenue of ₹8.89 Cr: Sini Pharma Private Limited ₹8.13 Cr (FY 2025); Sini Healthcare Llp ₹75.6 Lakh (FY 2024).

Nisarg Maheshkumar Patel held 1 earlier board appointment: Sini Brook Biotech Private Limited (Director, from 18 Feb 2022).

The current boards of Nisarg Maheshkumar Patel's companies include Maheshkumar Manilal Patel (Sini Pharma Private Limited), Siddharth Jayantibhai Patel (Sini Pharma Private Limited), Yashvant Naranbhai Patel (Sini Pharma Private Limited), Prakashkumar Babulal Shah (Serifos Pharma Private Limited), Sachin Mansukhbhai Patel (Serifos Pharma Private Limited), Bela Jayeshkumar Gandhi (Joyance Realtors Llp), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available